Correspondence 0001104659-23-079970 from Apogee Therapeutics, Inc. (APGE) (CIK 0001974640) (APGE)
Apogee Therapeutics, Inc. (APGE) (CIK 0001974640)
Date: July 11, 2023 · CIK: 0001974640 · Accession: 0001104659-23-079970
AI Filing Summary & Sentiment
File numbers found in text: 333-272831
Letter
VIA EDGAR AND EMAIL United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Attention: Arzhang Navai and Suzanne Hayes Re: Apogee Therapeutics, Inc. Registration Statement on Form S-1 (File No. 333-272831)
Dear Mr. Navai and Ms. Hayes:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between July 10, 2023 and the date hereof, approximately 3,300 copies of the Preliminary Prospectus, dated July 10, 2023, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement, as amended.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on July 13, 2023 or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Gibson, Dunn and Crutcher LLP, request by telephone that such Registration Statement be declared effective.
[signature page follows]
Very truly yours,
JEFFERIES LLC
Show Raw Text
CORRESP
1
filename1.htm
July 11, 2023
VIA EDGAR AND EMAIL
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Arzhang Navai and Suzanne Hayes
Re:
Apogee Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-272831)
Dear Mr. Navai and Ms. Hayes:
Pursuant to Rule 460 of the General Rules
and Regulations under the Securities Act of 1933, as amended, we wish to advise that between July 10, 2023 and the date hereof,
approximately 3,300 copies of the Preliminary Prospectus, dated July 10, 2023, were distributed to prospective underwriters,
institutional investors and prospective dealers in connection with the above-captioned Registration Statement, as amended.
We wish to advise you that the participating underwriters
have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange
Act of 1934, as amended.
We hereby join in the request of the Registrant
that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on July 13,
2023 or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Gibson, Dunn and Crutcher LLP,
request by telephone that such Registration Statement be declared effective.
[signature page follows]
Very truly yours,
JEFFERIES LLC
COWEN AND COMPANY, LLC
STIFEL, NICOLAUS & COMPANY,
INCORPORATED
GUGGENHEIM SECURITIES, LLC
As representatives of the Underwriters
JEFFERIES LLC
By:
/s/ Matthew Kim
Name: Matthew Kim
Title: Managing Director
COWEN AND COMPANY, LLC
By:
/s/ Bill Follis
Name: Bill Follis
Title: Managing Director
STIFEL, NICOLAUS & COMPANY,
INCORPORATED
By:
/s/ Nick Oust
Name: Nick Oust
Title: Managing Director
GUGGENHEIM SECURITIES, LLC
By:
/s/ Ronald Gerber
Name: Ronald Gerber
Title: Senior Managing Director
[Signature Page to Acceleration
Request Letter]